British Journal of Dermatology· 2020Q1
Classification of the cutaneous manifestations of <scp>COVID</scp> ‐19: a rapid prospective nationwide consensus study in Spain with 375 cases
- 1,238citations
- Q1SCImago
- 2020year
Short summary
A nationwide study in Spain classified COVID-19 skin manifestations into five patterns, finding that vesicular eruptions appear early, pseudo-chilblain lesions appear late, and severity correlates with lesion type.
AI-generated from the title and abstract; the full text is not read.
Key points
- Five distinct COVID-19 skin manifestation patterns were identified: pseudo-chilblain, vesicular, urticarial, maculopapular, and livedo/necrosis.
- Vesicular eruptions appeared early (15% before other symptoms), while pseudo-chilblain lesions appeared late (59% after other symptoms).
- Disease severity correlated with lesion type, ranging from less severe for acral lesions to more severe for other patterns.
- The classification helps clinicians recognize COVID-19, especially in patients with mild or few other symptoms.
AI-generated from the title and abstract; the full text is not read.
Abstract
BACKGROUND: The cutaneous manifestations of COVID-19 disease are poorly characterized. OBJECTIVES: To describe the cutaneous manifestations of COVID-19 disease and to relate them to other clinical findings. METHODS: We carried out a nationwide case collection survey of images and clinical data. Using a consensus we described five clinical patterns. We later described the association of these patterns with patient demographics, the timing in relation to symptoms of the disease, the severity and the prognosis. RESULTS: The lesions may be classified as acral areas of erythema with vesicles or pustules (pseudo-chilblain) (19%), other vesicular eruptions (9%), urticarial lesions (19%), maculopapular eruptions (47%) and livedo or necrosis (6%). Vesicular eruptions appear early in the course of the disease (15% before other symptoms). The pseudo-chilblain pattern frequently appears late in the evolution of the COVID-19 disease (59% after other symptoms), while the rest tend to appear with other symptoms of COVID-19. The severity of COVID-19 shows a gradient from less severe disease in acral lesions to more severe in the latter groups. The results are similar for confirmed and suspected cases, in terms of both clinical and epidemiological findings. Alternative diagnoses are discussed but seem unlikely for the most specific patterns (pseudo-chilblain and vesicular). CONCLUSIONS: We provide a description of the cutaneous manifestations associated with COVID-19 infection. These may help clinicians approach patients with the disease and recognize cases presenting with few symptoms. What is already known about this topic? Previous descriptions of cutaneous manifestations of COVID-19 were case reports and mostly lacked illustrations. What does this study add? We describe a large, representative sample of patients with unexplained skin manifestations and a diagnosis of COVID-19, using a consensus method to define morphological patterns associated with COVID-19. We describe five clinical patterns associated with different patient demographics, timing and prognosis, and provide illustrations of these patterns to allow for easy recognition.
The authors' abstract, as published at the source. British Journal of Dermatology, 2020 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Dermatology
DermatologyMedicine